IGEN INTERNATIONAL INC /DE 4
4 · IGEN INTERNATIONAL INC /DE · Filed Feb 18, 2004
Insider Transaction Report
Form 4
REES ANTHONY R
Director
Transactions
- Disposition to Issuer
Option to Buy
2004-02-13−10,000→ 0 totalExercise: $23.30From: 2001-06-06Exp: 2011-06-06→ Common Stock (10,000 underlying) - Disposition to Issuer
Option to Buy
2004-02-13−4,500→ 0 totalExercise: $15.69From: 2000-06-27Exp: 2010-06-27→ Common Stock (4,500 underlying) - Disposition to Issuer
Common Stock
2004-02-13−8,600→ 0 total
Footnotes (3)
- [F1]Pursuant to Agreement and Plan of Merger ("Agreement and Plan of Merger") dated July 24, 2003 among Roche Holding Ltd, 66 Acquisition Corporation II, IGEN International, Inc. and BioVeris Corporation (formerly known as IGEN Integrated Healthcare, LLC), each share of Common Stock of IGEN International, Inc. has been converted into the right to receive cash in an amount of $47.25, without interest, plus one share of common stock of BioVeris Corporation. The Agreement is more fully described in th e Registration Statement on Form S-4 (333-109196) as filed with the Securities and Exchange Commission on January 13, 2004.
- [F2]This option, which provided for vesting in installments, was cancelled in the Agreement and Plan of Merger, and in accordance therewith, each share under option was exchanged for a cash payment of $31.56 (representing the difference between the exercise price of the option and $47.25 per share) plus one (1) share of common stock of BioVeris Corporation.
- [F3]This option, which provided for vesting in installments, was cancelled in the Agreement and Plan of Merger, and in accordance therewith, each share under option was exchanged for a cash payment of $23.95 (representing the difference between the exercise price of the option and $47.25 per share) plus one (1) share of common stock of BioVeris Corporation.